[1] Ji L, Zhou A, Yu X, et al. Differential expression analysis of the SRB1 gene in fluconazole-resistant and susceptible strains of Candida albicans[J]. J Antibiot (Tokyo),2020,73(5):309-313. [2] Ahmad Khan MS, Alshehrei F, Al-Ghamdi SB, et al. Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis[J]. Future Sci OA,2020,6(2):FSO440. [3] Luna-Tapia A, DeJarnette C, Sansevere E, et al. The vacuolar Ca(2+) ATPase pump Pmc1p is required for Candida albicans pathogenesis[J]. mSphere,2019,4(1):1-10 [4] Jia C, Yu Q, Xu N, et al. Role of TFP1 in vacuolar acidification, oxidative stress and filamentous development in Candida albicans[J]. Fungal Genet Biol, 2014,71:58-67. [5] Jia Y, Tang RJ, Wang L, et al. Calcium-activated-calcineurin reduces the in vitro and in vivo sensitivity of fluconazole to Candida albicans via Rta2p[J]. PLoS One, 2012,7(10):e48369. [6] 项明洁,彭奕冰,徐炜新,等.白假丝酵母菌随机扩增多态DNA分型及其流行趋势分析[J].诊断学理论与实践,2007,6(1):40-42. [7] 王影, 吕权真, 阎澜. 白念珠菌锌簇转录因子编码基因mrr2敲除与鉴定[J]. 诊断学理论与实践, 2015, 14(2):164-168. [8] Noble SM, Johnson AD. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans[J]. Eukaryot Cell, 2005, 4(2):298-309. [9] Jia C, Zhang K, Yu Q, et al. Tfp1 is required for ion homeostasis, fluconazole resistance and N-Acetylglucosamine utilization in Candida albicans[J]. Biochim Biophys Acta,2015,1853(10 Pt A):2731-2744. [10] Li X, Sun S. Targeting the fungal calcium-calcineurin signaling network in overcoming drug resistance[J]. Future Med Chem,2016,8(12):1379-1381. |